Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has ...

Post-authorisation safety studies (PASS) are often seen simply as a regulatory necessity, a checkbox that ensures ongoing ...

The European orphan drug market is growing and is already comparable in size and scope to the US market. The European Union ...

Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...

The audited financial statements for the year ended December 31, 2024 included in the Company's Annual Report on Form 10-K ...

Italfarmaco S.p.A. today announced a comprehensive update on the regulatory and clinical advancements for givinostat, the ...

The Pediatric Praziquantel Consortium says it has achieved a milestone by administering arpraziquantel to the first preschool-aged child for the treatment of schistosomiasis, otherwise known as snail ...

Lecanemab and donanemab were hailed as 'the beginning of the end' of dementia last year, after studies showed they both slowed the progression of the memory-robbing illness.

More than 1000 patients have been recruited by Panthera Biopartners the UK’s largest SMO (Site Management Organisation) who recruit patients and runs clinical trials for the pharmaceutical industry.

Trump pauses tariffs on both Mexico and Canada until April after calls with Sheinbaum and Trudeau: Live - President clarifies ...

Russia's invasion of Ukraine has led to the largest population displacement crisis since WWII.. but where are Ukrainians going?

Sensorion (FR0012596468 - ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today ...